About Company
- Legal Name: NAGASE Europa GmbH
- Registered country: Germany
- Address: Immermannstr.65c
- Number of employees: 50 - 99
Description:
Established in 1832. Net sales of US$8billion. Highly technically oriented manufacturer. Production of oncology injection, sterile dosage, spray-drying technology, Intermediate, API and excipient. Nagase Medicals, a sterile dosage manufacturer,?completed a new building dedicated for oncology injection and liposomal dosage. Hayashibara, joined Nagase group in February 2012, is only one manufacturer of Trehalose and Pullulan in the world.
Business Activities
Active Pharmaceutical Ingredients (APIs)
Manufacturer
Contract & Outsourcing Services
Distributor
Pharma Chemicals
Distributor
Biopharmaceutical Products
Distributor
Innovator APIs
Distributor
Sales Markets
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
Our Products & Services
Certifications
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment